The global Artificial Intelligence In Drug Discovery Market was valued at USD 2.3 billion in 2025 and is projected to grow from USD 2.9 billion in 2026 to USD 13.8 billion by 2033, registering a remarkable CAGR of 24.8% from 2026 to 2033. North America dominated the market with a 52.8% revenue share in 2025, supported by strong pharmaceutical research capabilities, advanced AI...

According to a new report from Intel Market Research, the global AI Clinical Trial market was valued at USD 1.05 billion in 2025 and is projected to reach USD 3.45 billion by 2034, growing at a robust CAGR of 15 % during the forecast period (2025–2034). This expansion is driven by the escalating need for faster drug development, the rise of predictive analytics, and strong endorsement...

The North America Pharmaceutical Life Science Analytics Market is witnessing robust growth due to increasing digital transformation across the pharmaceutical industry, rising investments in advanced analytics technologies, and expanding adoption of artificial intelligence-driven solutions. Healthcare organizations and pharmaceutical companies throughout the region are utilizing predictive...